Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Avoiding Anticoagulation After IntraCerebral Haemorrhage — Stella

Home/Intracerebral Hemorrhage/Avoiding Anticoagulation After IntraCerebral Haemorrhage

View on ClinicalTrials.gov

Recruiting

Back to Intracerebral Hemorrhage trials

Avoiding Anticoagulation After IntraCerebral Haemorrhage

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(3 sites)

France

Hôpital Roger Salengro, CHU, Lille

GHICL, Lomme

CH De Tourcoing, Tourcoing

Key details

Phase

Large-scale testing

Sponsor

University Hospital, Lille

Collaborators

Ministry of Health, France, Institut National de la Santé Et de la Recherche Médicale, France

Enrollment target

~300 participants

Started

January 2019

Primary completion

January 2029

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.